HLA class I transgenic mice: development, utilisation and improvement.
about
Post-Genomics and Vaccine Improvement for LeishmaniaDevelopment of a humanized HLA-A2.1/DP4 transgenic mouse model and the use of this model to map HLA-DP4-restricted epitopes of HBV envelope proteinA detailed analysis of the murine TAP transporter substrate specificityHLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.Characterization of the specific CD4+ T cell response against the F protein during chronic hepatitis C virus infectionA Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8+ T Cells Essential for the Protection against ExpeHumanized mouse models to study human diseasesIdentification of conserved and HLA promiscuous DENV3 T-cell epitopes.Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccineTherapeutic Vaccine Strategies against Human Papillomavirus.Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patientsImmunocompetent mouse models to evaluate intrahepatic T cell responses to HCV vaccines.West Nile virus T-cell ligand sequences shared with other flaviviruses: a multitude of variant sequences as potential altered peptide ligandsReverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles.Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humansEfficient generation of B2m-null pigs via injection of zygote with TALENsImmunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses.Identification of a novel PD-L1 positive solid tumor transplantable in HLA-A*0201/DRB1*0101 transgenic miceDNA fusion gene vaccines induce cytotoxic T-cell attack on naturally processed peptides of human prostate-specific membrane antigen.Introduction of a point mutation into an HLA class I single-chain trimer induces enhancement of CTL priming and antitumor immunity.Alternative to Chemotherapy-The Unmet Demand against Leishmaniasis.
P2860
Q26752532-3C1A964D-D324-42CC-BE35-43298860ABB4Q28731516-C546A088-9FC5-4DDE-B691-673A7035D9C2Q33342843-213B2789-FADB-41FD-A33B-69DA914CB7D9Q33755226-F3369582-C9B1-4257-93A4-922659CB91EBQ33769438-AA17AE9F-8BCF-4B47-9295-9F7F309B0B98Q33790313-5A883E6B-70E3-470C-8E44-AF67936A1D91Q33941638-E034EE00-9BFE-4C02-B70D-1049CDE1CED3Q35018972-06F38E3B-BF40-45F8-B819-82F1C94A0368Q35326248-068910F1-602D-4746-8FCB-60544A4436E2Q35826752-E76D7FF1-2012-4C4F-8BDF-67052B1DCDE1Q35857548-E4A4BB4F-1EA4-4DE2-9110-2B0F00A2093AQ35886734-BBA35866-051D-4FE2-A038-3FFE55DDB87AQ36155428-50AC5B96-1932-49E8-8652-D04F604699F6Q36471831-DE1E540F-C5DC-4B3E-AC7F-39B3BFFD3BF2Q37089515-991718AD-B41A-4AE3-A072-86688C2A7002Q37508228-1BDC7C10-49AA-41DA-A890-4A283A6E779DQ37963480-4B428AF3-80AA-47C0-86D1-7DD3E8007AC9Q38706572-9BC95379-04C9-4123-B57B-D901460498AAQ39538214-49DBD882-5838-4EED-9D85-489CBBF9F18EQ40898202-74F6F8E4-F66E-48E2-9A87-11669F5E0DB4Q50130388-46F85C31-DE0D-420E-8A29-B48B4754819C
P2860
HLA class I transgenic mice: development, utilisation and improvement.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
HLA class I transgenic mice: development, utilisation and improvement.
@ast
HLA class I transgenic mice: development, utilisation and improvement.
@en
type
label
HLA class I transgenic mice: development, utilisation and improvement.
@ast
HLA class I transgenic mice: development, utilisation and improvement.
@en
prefLabel
HLA class I transgenic mice: development, utilisation and improvement.
@ast
HLA class I transgenic mice: development, utilisation and improvement.
@en
P2860
P356
P1476
HLA class I transgenic mice: development, utilisation and improvement.
@en
P2093
Steve Pascolo
P2860
P304
P356
10.1517/14712598.5.7.919
P407
P577
2005-07-01T00:00:00Z